Bilal Piperdi

Bilal Piperdi

Company: Gilead Sciences

Job title: Vice President, Clinical Development Oncology


Trodelvy-Immunotherapy Combinations In Solid Tumors: Rationale & Emerging Data 9:15 am

Recapping and contextualizing recent data from Phase II EVOKE-02 trial of Troveldy-Keytruda combinations in lung cancer Evaluating rationale and design of Trodelvy-immunotherapy combinations in other solid tumors Breaking down the potential – what are the route forward and potential of novel ADC-immunotherapy combinations?Read more

day: Day Two AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.